Ciprian Tomuleasa

About Ciprian Tomuleasa

Ciprian Tomuleasa, With an exceptional h-index of 37 and a recent h-index of 27 (since 2020), a distinguished researcher at Universitatea de Medicina si Farmacie Iuliu Hatieganu,

His recent articles reflect a diverse array of research interests and contributions to the field:

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options

Immune Therapies of B-cell Acute Lymphoblastic Leukaemia in Children and Adults

Design and implementation of a humanitarian cancer care programme for Ukrainian refugees in Moldova and Romania

Anaesthesia Management for Giant Intraabdominal Tumours: A Case Series Study

Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2

Low-Dose Decitabine Plus Venetoclax As Frontline Treatment of Acute Myeloid Leukemia

Preclinical Evaluation of an Anti-CD41 CAR T Cell in Acute Megakaryoblastic Leukemia on in Vitro and In Vivo Models

Ciprian Tomuleasa Information

University

Position

___

Citations(all)

4278

Citations(since 2020)

2709

Cited By

2673

hIndex(all)

37

hIndex(since 2020)

27

i10Index(all)

97

i10Index(since 2020)

75

Email

University Profile Page

Google Scholar

Top articles of Ciprian Tomuleasa

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options

Annals of Hematology

2024/3/4

Immune Therapies of B-cell Acute Lymphoblastic Leukaemia in Children and Adults

2024/3/2

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

Robert Peter Gale
Robert Peter Gale

H-Index: 58

Design and implementation of a humanitarian cancer care programme for Ukrainian refugees in Moldova and Romania

The Lancet Oncology

2024/3/1

Horia Vulpe
Horia Vulpe

H-Index: 5

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

Anaesthesia Management for Giant Intraabdominal Tumours: A Case Series Study

Journal of Clinical Medicine

2024/2/26

Constantin Bodolea
Constantin Bodolea

H-Index: 6

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants

2024/2/16

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2

JCI insight

2020/1/1

Xinna Zhang
Xinna Zhang

H-Index: 36

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

Low-Dose Decitabine Plus Venetoclax As Frontline Treatment of Acute Myeloid Leukemia

Transplantation and Cellular Therapy

2024/2/1

Mihnea Zdrenghea
Mihnea Zdrenghea

H-Index: 15

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

Preclinical Evaluation of an Anti-CD41 CAR T Cell in Acute Megakaryoblastic Leukemia on in Vitro and In Vivo Models

Transplantation and Cellular Therapy

2024/2/1

Understanding DNA Epigenetics by Means of Raman/SERS Analysis for Cancer Detection

Biosensors

2024/1/12

A mathematical model of clonal hematopoiesis explaining phase transitions in myeloid leukemia

arXiv preprint arXiv:2401.05316

2024/1/10

Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical …

2024/1

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

Ioana Berindan Neagoe
Ioana Berindan Neagoe

H-Index: 44

Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)

2023/8/15

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

Optimization of tyrosine kinase inhibitor-loaded gold nanoparticles for stimuli-triggered antileukemic drug release

Journal of Functional Biomaterials

2023/7/27

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

MDS cells maturation induced by ATRA differentiating agent in myelodysplastic syndromes.

Studia Universitatis Babes-Bolyai, Historia Artium

2023/7/1

Victor Greiff
Victor Greiff

H-Index: 17

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

RNA sequencing suggests that non‐coding RNAs play a role in the development of acquired haemophilia

Journal of Cellular and Molecular Medicine

2023/7

Rare within Rare: A Girl with Severe Haemophilia A and Turner Syndrome

Journal of Clinical Medicine

2023/11/30

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

The tumor suppressor functions of ubiquitin ligase KPC1: from cell-cycle control to NF-κB regulator

2023/6/2

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

Meter: A Multi-Country, Real-World Chart Review Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients with Myelofibrosis

Blood

2023/11/28

BMS-986158, a potent BET inhibitor, in combination with ruxolitinib or fedratinib in patients (pts) with intermediate-or high-risk myelofibrosis (MF): updated results from a …

Blood

2023/11/28

Efficacy of SB12 (Eculizumab Biosimilar) in Asian and Non-Asian Patients with Paroxysmal Nocturnal Hemoglobinuria: Subgroup Analysis of a Global Phase III Randomized Controlled …

Blood

2023/11/28

Ciprian Tomuleasa
Ciprian Tomuleasa

H-Index: 27

Jihye Park
Jihye Park

H-Index: 6

Paola Russo
Paola Russo

H-Index: 25

See List of Professors in Ciprian Tomuleasa University(Universitatea de Medicina si Farmacie Iuliu Hatieganu)